FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Vertex Pharmaceuticals
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy
September 18, 2025
From
Vertex Pharmaceuticals
Via
Business Wire
Tickers
VRTX
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England
January 31, 2025
From
Vertex Pharmaceuticals
Via
Business Wire
Tickers
VRTX
Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England
August 07, 2024
From
Vertex Pharmaceuticals
Via
Business Wire
Tickers
VRTX
Vertex Announces $50 Million Commitment to Health Equity With Three Initial Grants
May 17, 2022
From
Vertex Pharmaceuticals
Via
Business Wire
Tickers
VRTX
